Article Information
History
- June 22, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lan Chen1,
- Zhen-Yu Zhang1,
- Jian-Guo Fu1,
- Zhi-Peng Feng1,
- Su-Zhen Zhang1,
- Qiu-Ying Han1,
- Xiao-Bin Zhang1,
- Xiong Xiao2,
- Hui-Min Chen3,
- Li-Long Liu4,
- Xian-Li Chen5,
- Yu-Pei Lan6,
- De-Jin Zhong7,
- Lan Hu8,
- Jun-Hui Wang8,
- Xing-Hua Yu1,
- Dan-Yang She9,*,
- Yong-Hong Zhu10,* and
- Zhen-Yu Yin1,*
- 1Zhongshan Hospital, Xiamen University, Xiamen, Fujian, China
- 2Department of Respiratory, Xiamen Branch of Zhongshan Hospital Affiliated to Fudan University, Xiamen, Fujian, China
- 3Department of Intensive Care Unit, Xiamen Third Hospital, Xiamen, Fujian, China
- 4Department of Infectious Disease, Hongai Hospital, Xiamen, Fujian, China
- 5Department of Infectious Disease, Xiang’an Hospital Affiliated to Xiamen University, Xiamen, Fujian, China
- 6General Office, Xiamen Haicang Hospital, Xiamen, Fujian, China
- 7Department of Gastroenterology, Xiamen Changgen Hospital, Xiamen, Fujian, China
- 8Optics Valley Branch of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Wuhan, Hubei, China
- 9Department of Pulmonary and Critical Care Medicine, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
- 10Early Clinical Development of Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center, Shanghai 201203, China
- ↵*Corresponding author:
Zhen-Yu Yin, Zhongshan Hospital, Xiamen University,, Department of Hepatobiliary Surgery, 201, Hubin South Road, Siming qu, Xiamen, Fujian 361004, China, E-mail: yinzy{at}xmu.edu.cn, Dan-Yang She, Department of Pulmonary and Critical Care Medicine, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China, E-mail: dysheh{at}163.com, Yong-Hong Zhu, Early Clinical Development of Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center, Shanghai 201203, China, E-mail: yonghong.zhu.yz2{at}roche.com
Posted June 22, 2020.
Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study
